Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia

Published:2014-10 Issue:15 Volume:50 Page:2685-2694
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bhojwani Deepa,Darbandi Rashid,Pei Deqing,Ramsey Laura B.,Chemaitilly Wassim,Sandlund John T.,Cheng Cheng,Pui Ching-Hon,Relling Mary V.,Jeha Sima,Metzger Monika L.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group;Hunger;J Clin Oncol,2012

2. Treating childhood acute lymphoblastic leukemia without cranial irradiation;Pui;N Engl J Med,2009

3. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia;Parsons;Blood,1997

4. Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase;Steinherz;Cancer,1994

5. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline;Berglund;J Clin Endocrinol Metab,2012

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A lipid index for risk of hyperlipidemia caused by anti-retroviral drugs;Antiviral Research;2024-03

2. A Review of Acute Lymphocytic Leukemia (ALL) in the Pediatric Population: Evaluating Current Trends and Changes in Guidelines in the Past Decade;Cureus;2023-12-04

3. Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta‐analysis;Pediatric Blood & Cancer;2023-09-30

4. Very severe hypertriglyceridemia complicating pediatric acute lymphoblastic leukemia treatment: a call for management guidelines;Journal of Pediatric Endocrinology and Metabolism;2023-07-06

5. Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies;Cancer Chemotherapy and Pharmacology;2023-05-18